MCM5 was also highly expressed in many tumors, such as thyroid cancer cells (Mio et al., 2016) and breast cancer (Eissa et al., 2015), but its expression status and prognostic value in lung cancer have yet to be evaluated. Here, MCM5 is linked to thyroid cancer.